CardiaTec Biosciences

📍 Cambridge, United Kingdom🗓 Founded 2021👥 8 employees💰 Last funded Apr 2022
Biotechnology Research🌐 cardiatec.ai
Website LinkedIn
CardiaTec is applying artificial intelligence on large-scale human multi-omics data to develop the next generation of cardiovascular disease drug targets.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in CardiaTec Biosciences?
CardiaTec Biosciences has 1 investors on record on gritt.io, including 1 early-stage backers.
When did CardiaTec Biosciences last raise funding?
The most recent investment in CardiaTec Biosciences recorded on gritt.io was in April 2022.
When was CardiaTec Biosciences founded?
CardiaTec Biosciences was founded in 2021.
What industry is CardiaTec Biosciences in?
CardiaTec Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CardiaTec Biosciences based?
CardiaTec Biosciences is headquartered in Cambridge, United Kingdom.